AN2 Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has AN2 Therapeutics's balance sheet done over the years? Its assets were worth $138,744,000 last year, which is more than in the previous period. 10% of AN2 Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $14,043,000, which means an increase by 95% compared compared to last year.

Debt to Assets

AN2 Therapeutics, Inc. (NASDAQ:ANTX): Debt to assets
2019 5700000 887K 15.56%
2020 4234000 24.55M 579.9%
2021 65316000 112.72M 172.59%
2022 102560000 7.18M 7.01%
2023 138744000 14.04M 10.12%

ANTX Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
15.64M27.21M12.09M4.07M5.59M
Short term investments
91.64M68.84M46.45M00
Net receivables
00000
Inventory
00000
Other current assets
3.21M2.56M1.55M164K102K
Total current assets
110.50M98.62M60.10M4.23M5.7M
Non-current assets:
Property, Plant and Equipment
053K000
Goodwill
00000
Intangible assets
00000
Long term investments
27.19M3.21M3.48M00
Other non-current assets
1.04M667K1.72M00
Total non-current assets
28.23M3.93M5.21M00
Total assets
138.74M102.56M65.31M4.23M5.7M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
053K000
Total current liabilities
14.04M7.18M3.39M1.45M159K
Non-current liabilities:
Long term debt
053K00728K
Deferred tax
00000
Other non-current liabilities
0-51K109.33M23.09M0
Total non-current liabilities
02K109.33M23.09M728K
Total liabilities
14.04M7.18M112.72M24.55M887K
Data sourceData source